% | $
Quotes you view appear here for quick access.

Repligen Corporation Message Board

  • quantify000 quantify000 Aug 19, 2013 4:26 PM Flag

    Smith article

    Really really in-depth BUT the bottom line / most important singular item is how we use da cash / when we use da cash / anything close to Novazyme if we are fortunate to buy a $50M plus company that can push us well into $100M in bioprocessing sales - that would be first choice. Doubt we will be that lucky so probably a series of smaller moves incrementally increasing top / bottom line and getting us to $20 in next 3 years.

25.92+0.21(+0.82%)May 5 4:00 PMEDT